Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2012

Jun 11, 2012

30291_dirs_2012-06-11_b4833350-2e11-475b-a944-48e9cc3b5041.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2012-06-07

Reporting Person: Posner Brian S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-06-07 Common Stock M 2500 $71.38 Acquired 15130 Direct
2012-06-07 Common Stock S 2500 $135.00 Disposed 12630 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-06-07 Stock Option (Right to Buy) $71.38 M 2500 Disposed 2018-07-22 Common Stock (2500) Direct

Footnotes

F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.